Attached files
file | filename |
---|---|
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | f10q0617_ex31-1bisoncapital.htm |
10-Q - QUARTERLY REPORT - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | f10q0617_bisoncapital.htm |
Exhibit 32.1 & 32.2
CERTIFICATION OF
PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Bison Capital Acquisition Corp. (the “Company”) on Form 10-Q for the period ended June 30, 2017 (the “Report”), I, James Jiayuan Tong, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 11, 2017 | /s/ James Jiayuan Tong | |
James Jiayuan Tong | ||
Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer and Director |